Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas

American Journal of Pathology

Volumn 160, Issue 4, 2002, Pages 1207-1214

  Konishi, Noboru ^a   Nakamura, Mitsutoshi ^a   Kishi, Munehiro ^a   Nishimine, Masayoshi ^a   Ishida, Eiwa ^a   Shimada, Keiji ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN INK4A; PROTEIN MDM2; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P73; PROTEIN RB1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; DNA METHYLATION; GENE DELETION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; SCORING SYSTEM; SIGNAL TRANSDUCTION;

EID: 0036107973     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62547-3     Document Type: Article

References (40)

1. Genetic changes in prostate cancer
2. Comparative studies of prostate cancer in Japan versus the United States. A review
3. Epigenetic mechanisms for progression of prostate cancer
4. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines
5. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
6. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
7. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
8. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
9. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
10. Cancer. Death and methylation
11. ARF
12. ARF deletion and methylation in genetic pathways to glioblastomas
13. ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2
14. A gene hypermethylation profile of human cancer
15. INK4a genes in human esophageal squamous cell carcinoma
16. INK4B gene alterations with immunohistochemical studies in human prostate carcinomas
17. Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas
18. Histologic grading of prostate cancer: A perspective
19. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
20. Promoter hypermethylation of the RB1 gene in glioblastomas
21. INK4a methylation and p53 mutational status
22. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island
23. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation
24. INK4a genes in primary central nervous system lymphomas
25. Complete genomic sequence of the human retinoblastoma susceptibility gene
26. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma
27. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence
28. The INK4A/ARF locus and its two gene products
29. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma
30. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
31. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers
32. Absence of WAF1 mutations in a variety of human malignancies
33. waf1/cip1 protein in prostate cancer
34. KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy
35. KIP1 p27KIPI gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma
36. p27/Kip1 mutation found in breast cancer
37. Aberrant p27Kip1 promoter methylation in malignant melanoma
38. Translational control of p27Kip1 accumulation during the cell cycle
39. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
40. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage